论文部分内容阅读
近年来,在世界范围内,新的医药品种开发速度快,上市量不少,收效不小。据英国《Scrip》杂志和世界卫生组织的《Drug Information》报导,1982—1984年开发的医药品种达115种,这些药物在临床上已经作出了贡献,但在疗效上总的来讲,仍是一般的多,有特球突破的少,甚至有的上市不久,由于安全与功效等原因,又宣布停售的。有如zomax及戊烯保泰松等。现将近年来国外出现的、较成熟的若干品种,除国内已经研究试制或投产的品种外,摘要报导如下:
In recent years, in the world, the development of new pharmaceutical varieties is fast with a large amount of listing and no small effect. According to “Scrip” magazine and the World Health Organization’s “Drug Information,” 115 species of medicinal products were developed in 1982-1984 and these drugs have made clinical contributions. However, in terms of efficacy, they are still In general, there are few special ball breakthroughs, and some even listed shortly, due to safety and efficacy and other reasons, they also announced the suspension. As zomax and pentene phenylbutazone and so on. Now in recent years abroad, a number of more mature species, in addition to the domestic trial or production of varieties, the summary is reported as follows: